• Recent Posts

  • The Use of Intent Scale Translations to Predict Purchase Interest
  • Mitigate Medical Product Risk and Improve Safe Use

• REMS Zone

  • Untitled
  • FDA approves new treatment for most common type of skin cancer
  • FDA approves Inlyta to treat patients with a type of advanced kidney cancer
  • FDA permits marketing of first test for risk of rare brain infection in some people treated with Tysabri
  • FDA approves Voraxaze to treat patients with toxic methotrexate levels

BioTrak Research Tel:760.448.4820
Fax: 760.603.9535
contactus@biotrak.com